Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

MannKind Corp (NASDAQ:MNKD)

1.41
Delayed Data
As of Aug 21
 -0.05 / -3.42%
Today’s Change
0.67
Today|||52-Week Range
4.85
-55.71%
Year-to-Date

Today’s Trading

Previous close1.46
Today’s open1.45
Day’s range1.40 - 1.45
Volume968,630
Average volume (3 months)3,087,414
Market cap$152.8M
Dividend yield--
Data as of 08/21/2017

Growth & Valuation

Earnings growth (last year)--
Earnings growth (this year)-169.12%
Earnings growth (next 5 years)+26.80%
Revenue growth (last year)--
P/E ratio1.0
Price/Sales1.68
Price/Book--

Competitors

 Today’s
change
Today’s
% change
RDHLRedhill Biopharma Lt...-0.13-1.45%
SMMTSummit Therapeutics ...+0.12+0.98%
CEMPCempra Inc-0.10-3.39%
OCXOncoCyte Corp-0.20-4.04%
Data as of 3:59pm ET, 08/21/2017

Financials

Next reporting dateNovember 8, 2017
EPS forecast (this quarter)-$0.24
Annual revenue (last year)$174.8M
Annual profit (last year)$125.7M
Net profit margin71.91%

Profile

Sector
Health Technology
Industry
Biotechnology
Chief Executive Officer &
Director
Michael E. Castagna
Chief Financial Officer &
Chief Accounting Officer
Steven Binder
Corporate headquarters
Westlake Village, California

Forecasts